-Livemint.com For the first time during the tenure of the present government, overall inflation of food articles is negative, implying a decline in prices Last week the India Meteorological Department (IMD) presented its first forecast for the monsoon this year. The forecast at 97% of the long period average (LPA) suggested yet a third year of normal monsoon rains, following 2016 and 2017. This should have ideally brought cheer to farmers struggling...
More »SEARCH RESULT
Total Matching Records found : 138
MSP for Jowar: At 150% of cost, it will distort market price -Prabhudatta Mishra
-Financial Express If the government implements the assured minimum support price at one and a half times the production cost, as promised, it would jack up consumer prices of jowar and distort the market dynamics of the “poor man’s cereal”. Besides, the measure would also dampen exports, analysts warn. At 150% of the cost (A2+FL), the MSP for jowar for the next season could be at least 37% higher than the...
More »Transfer of NPPA head who capped stent, implant prices sparks protests
-The Times of India The transfer of the chairman of the National Pharmceutical Pricing Authority, Bhupendra Singh, who had capped the price of stents and knee implants and exposed the huge margins being charged by corporate hospitals has evoked howls of protest from public health activists. RSS-affiliate Swadeshi Jagran Manch too has taken exception to the move, tweeting sarcastically about the “reward” given to a bureaucrat for doing a good job. The All...
More »Private hospitals making profits of up to 1,737% on drugs, consumables and diagnostics: Study -Rema Nagarajan
-The Times of India NEW DELHI: An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on drugs, consumables and diagnostics and that these three accounts for about 46% of a patient’s bill. The analysis, released on Tuesday, noted that “the major beneficiaries of profits in all these cases because of...
More »Consumables now costlier than stents in angioplasty -Rema Nagarajan
-The Times of India NEW DELHI: Even as stent prices have been capped, the cost of the three main consumables used in angioplasty have, in many cases, become even more expensive than stents as hospitals try to make up for the huge margins they lost on stents. The modus operandi is same as in the case of stents before the price cap. Though the consumables are bought at a third or less...
More »
